Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group
(Q50561845)
scientific article published in May 1998
scientific article published in May 1998
Language:
Current Data About
Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group
other details
| description | scientific article published in May 1998 |
External Links
| (P356) |
10.1006/GYNO.1998.4984
|
| (P698) |
9625618
|